Home > Insider Trading > Filing (0001093557-23-000077)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1914994	Vincent Matthew Dolan	6340 Sequence Drive San Diego CA 92121	Svp Corporate Strategy-Develop	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-03-10	1,370	$111.40	46,935	No	4	D	Direct
Common Stock	Disposition	2023-03-10	1,650	$111.40	45,285	No	4	D	Direct
Common Stock	Disposition	2023-03-10	2,397	$111.40	42,888	No	4	D	Direct
Common Stock	Disposition	2023-03-10	787	$111.40	42,101	No	4	D	Direct
Common Stock	Disposition	2023-03-13	6,229	$106.27	35,872	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	D	Direct
No	4	D	Direct
No	4	D	Direct
No	4	D	Direct
No	4	S	Direct

Footnotes

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Included in this number are 33,569 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
On December 15, 2021, Mr. Dolan adopted a 10b5-1 Plan which was amended on December 6, 2022. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Dolan. The shares set forth above were sold pursuant to the 10b5-1 Plan.